Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,5611,580 of 20,252 grants

Active NON-SBIR/STTR RPGS
NEUROD1 function in SCLC fate and plasticity
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2029

Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine lung tumor responsible for > 30,000 deaths annually in the US. SCLC has a two-year survival rate of ~6% with...

$5.5M
USD
Active NON-SBIR/STTR RPGS
Development of Novel Antibody Conjugates for Cancer Immunotherapy
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2024 – 2029

Abstract Targeted protein degradation by chimeric molecules has emerged as a novel therapeutic modality. The bifunctional chimeric molecules usually have one end binding to the pro...

$3.95M
USD
Active NON-SBIR/STTR RPGS
Optimizing anti-wild-type IDH1 therapy in pancreatic cancer
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2024 – 2029

Pancreatic ductal adenocarcinoma (PDAC) is the most deadly of the common cancers, with limited treatment options. Chemotherapy is marginally effective, while targeted or immunologi...

$6.91M
USD
Completed NON-SBIR/STTR RPGS
Modulation of ITK signaling for sustainable adoptive T cell therapy
NATIONAL CANCER INSTITUTE Louisiana State University A&M Col Baton... United States 2024 – 2026

Project Summary/Abstract CAR-T cell therapy has demonstrated success in curing B cell (CD19+) malignancies and has shown promise in treating lupus. However, the cytotoxic and short...

$1.75M
USD
Active NON-SBIR/STTR RPGS
AYA ACCESS Study: An enhanced eHealth and Chat-bot enabled delivery model for clinical genetic services in community AYA cancer patients
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2024 – 2029

Each year, approximately 90,000 adolescents and young adults (AYA; National Cancer Institute defined age 15- 39-years at cancer diagnosis) are diagnosed with cancer. Despite increa...

$7.54M
USD
Completed OTHER RESEARCH-RELATED
2024 Annual Meeting of the American Society for Investigative Pathology
NATIONAL CANCER INSTITUTE American Society/Investigative Pathology United States 2024 – 2025

The 2024 Annual Meeting of the American Society for Investigative Pathology (ASIP) will be held April 20-23 at Renaissance Baltimore Harborplace Hotel in Baltimore, MD. The Annual...

$150K
USD
Completed OTHER RESEARCH-RELATED
Cell Signaling in Cancer- From Mechanisms to Therapy
NATIONAL CANCER INSTITUTE Federation of Amer Soc for Exper Biology United States 2024 – 2025

PROJECT SUMMARY ABSTRACT Decades of research has revealed the complexity of cellular signaling networks involved in control of cellular processes and their exceptional vulnerabilit...

$100K
USD
Completed NON-SBIR/STTR RPGS
ANCHOR Correlative Science Administrative Supplement
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2024 – 2024

7. Project Summary / Abstract The ANCHOR Study is an ongoing, longitudinal, multicenter trial in people living with HIV (PLWH), which demonstrated that treating anal high-grade squ...

$6.5M
USD
Active NON-SBIR/STTR RPGS
Research Supplement to Promote Diversity in Health-Related Research
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2027

A defining property of cancers that lack intrinsic immune surveillance is the absence of costimulatory context in myeloid cells—macrophages and dendritic cells (DC)—preventing tumo...

$242.1K
USD
Active NON-SBIR/STTR RPGS
Glial immune signaling in radiation-induced brain injury
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2024 – 2026

ABSTRACT (parent award, R01 CA251110), unchnaged Cranial radiation therapy (CRT) for the treatment of CNS cancers often leads to unintended and debilitating cognitive impairments....

$388.4K
USD
Active NON-SBIR/STTR RPGS
Targeting Microenvironmental Signals in Myeloid Malignancies
NATIONAL CANCER INSTITUTE University of Rochester United States 2024 – 2027

ABSTRACT Interactions of stem cells with their surrounding microenvironment are known to be essential for both normal development, and for sustaining self-renewing adult stem cells...

$209.9K
USD
Completed NON-SBIR/STTR RPGS
Supportive Care Needs in Asian Americans with Metastatic Cancer
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2024 – 2025

PROJECT SUMMARY/ABSTRACT Cancer is the leading cause of death for Asian Americans, the fastest growing U.S. immigrant group projected to outnumber Latinx Americans by 2065. Provisi...

$285K
USD
Active NON-SBIR/STTR RPGS
MYCN drives a ferroptotic vulnerability in neuroblastoma
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2028

Summary: Apoptosis is a type of programmed cell death and has for a long time been appreciated to be a hallmark of cancer cells. In recent years, drugs targeting the apoptotic path...

$399.4K
USD
Completed NON-SBIR/STTR RPGS
Administrative Supplement to Existing NIH Grant-Purchase of a Equipment
NATIONAL CANCER INSTITUTE Methodist Hospital Research Institute United States 2024 – 2024

Project Summary/Abstract Malignant brain tumors are aggressive cancers that have high proliferative rates with much higher energy requirements and high mortality rates. Despite int...

$142.4K
USD
Active NON-SBIR/STTR RPGS
Mechanistic studies of hirsutinolides and azetidine based small molecule inhibitors of STAT3
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2024 – 2029

Project Summary/Abstract Triple-negative breast cancer (TNBC) is generally treated with chemotherapy, which only achieves incomplete response. Relapsed disease has no new treatment...

$1.29M
USD
Completed RESEARCH CENTERS
Exploring m6A RNA Modification in HIV-associated Cancers in Aging Populations (HIV-Associated Cancers in Aging Populations)
NATIONAL CANCER INSTITUTE University of Iowa United States 2024 – 2026

Abstract People living with HIV (PWH) have an increased incidence of cancers and worse outcomes than those not infected with HIV. People at the age of 50 or older also have increas...

$1.88M
USD
Active TRAINING, INDIVIDUAL
Maximizing Selective Inhibition of Clinically Observed MET Mutants
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2024 – 2027

PROJECT SUMMARY On-target resistance to small-molecule inhibitor therapy is a major challenge in cancer treatment. While the design of novel compounds remains an important long-ter...

$413.4K
USD
Active TRAINING, INDIVIDUAL
Elucidation of the Mechanism of Microhomology-Mediated End Joining by DNA Polymerase Theta
NATIONAL CANCER INSTITUTE Scripps Research Institute, The United States 2024 – 2027

PROJECT SUMMARY Double-stranded DNA breaks (DSBs) are a severe form of DNA damage that can give rise to devastating chromosomal aberrations. While DSBs are usually repaired with hi...

$742.8K
USD
Completed NON-SBIR/STTR RPGS
Investigating lipid phenotype as a metabolic adaptation to microenvironmental stress
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2024 – 2026

Breast cancers emerge through a years-long process of somatic evolution within the physical constraint of milk ducts, characterized by accumulation of heritable genetic and epigene...

$842.5K
USD
Active RESEARCH CENTERS
Cornell FIRST
NATIONAL CANCER INSTITUTE Cornell University United States 2024 – 2026

Cornell University aims to increase the number of minoritized faculty in the biological, biomedical, and health sciences through establishing an NIH FIRST Program at Cornell Univer...

$332.2K
USD